Monday, 28 March 2016

Possibilities Come to Life: 5 Years of Cancer Research Realized ARTICLE 2 Induced Stem Cells: They're Not All Equal

Cellular reprogramming allows scientists to generate cells for the study of cancer in laboratory settings. These cells are referred to as pluripotent stem cells or iPSCs. Until recently, it was assumed that all iPSCs, regardless of their origins,had the same capacity for differentiation, meaning they possessed the same ability to turn into a mature cell in any tissue. Dr. Mick Bhatia's lab set out to determine whether or not this was true. What they found is revolutionizing stem cell therapy, disease modelling and personalized drug discoveries.
See more in this month's column in the Londoner from our guest columnist Paige Collins of the Stem Cell and Cancer Research Institute, McMaster University, Hamilton.
“Human blood cells in a dish.  These cells were reprogrammed to stem cells from blood and were 10x more effective than using skin as a starting tissue.” 

For more information on the work being done at the Cell and Cancer Research Institute visit or their blog

No comments:

Post a Comment